GlassScriptPhysician profile
Ashley N Szalkowski
NPI 1336633262
$3,749.62
in general payments reported to CMS, 2019-2025
14 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $230 · 2021: $352 · 2022: $247 · 2024: $1,971 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,098.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,500.00 | 2024 | M22 |
| Allergan, INC. | $664.95 | 2019-2022 | |
| Alcon Vision LLC | $385.67 | 2024-2025 | Dailies Total1, Eysuvis, Total30 |
| Aerie Pharmaceuticals, INC. | $270.93 | 2019-2020 | |
| Shire North American Group INC | $146.74 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.67 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $124.99 | 2024 | Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $121.77 | 2022 | |
| Spark Therapeutics, INC. | $119.69 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $107.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $90.84 | 2020 | |
| Rayner Intraocular Lenses Limited | $39.13 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Dompe US, INC. | $28.73 | 2024 | Oxervate |
| Biotissue Holdings INC. | $19.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Szalkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.